WellTheory, a virtual care platform focused on autoimmune disease, has launched a Postpartum Program designed to support women navigating hormonal shifts that can trigger or worsen autoimmune symptoms after childbirth.
Autoimmune disease affects more than 50 million people in the United States, and 80% of patients are women. Pregnancy and childbirth are among the most significant hormonal shifts in a woman’s life and are common triggers for new diagnoses or flare-ups. However, postpartum support in traditional healthcare typically ends within weeks of delivery, even as hormonal changes continue for months.
“We’ve seen this pattern repeatedly in our patient population – women who were managing their health before pregnancy suddenly experience new or worsening symptoms after giving birth,” said Ellen Rudolph, CEO and Co-Founder of WellTheory. “When postpartum hormonal changes are treated as part of autoimmune care, women are better able to manage symptoms and return to feeling like themselves. This program puts structure around the care our teams have already been providing and ensures women have support during a period that’s often overlooked.”
The program includes personalized care plans, ongoing one-on-one support from autoimmune and hormonal health experts, and advanced hormonal testing including assessment of sex hormones, cortisol levels, and their metabolites.
“My own wife went through this during the postpartum period, which made it clear how little support exists for women at this stage,” said Wallace Torres, Co-Founder of WellTheory. “This program is rooted in what we’ve seen firsthand and what women have been asking for.”
Women make up more than 70% of WellTheory’s population. The Postpartum Program follows the launch of the company’s Hormonal Health Program, which supports women managing autoimmune disease alongside conditions such as PCOS, endometriosis, and menopause.
